Advance Your Infectious Disease Research with ACROBiosystems

As we step into the new year, Millennium Science is excited to partner with you in advancing your research! Whether you’re embarking on groundbreaking projects or tackling routine experiments, our exclusive selection of ACROBiosystems reagents for infectious disease research is designed to support every stage of your work. With special offers on premium products, we are committed to providing you with the tools needed to achieve precise, reliable results in virology and immunology studies.

ACROBiosystems is a trusted global leader in the development of high-quality recombinant proteins, antigens, antibodies, and assay kits for infectious disease research. Their reagents are widely used in vaccine development, antibody screening, diagnostic assay development, and therapeutic drug discovery. With a comprehensive portfolio spanning immunology, oncology, and virology, ACROBiosystems ensures reproducibility and accuracy in scientific experiments.

Key Benefits of ACROBiosystems Reagents:

• High Purity & Bioactivity – Ensuring reliable and consistent experimental results.
• Extensive Product Portfolio – Covering a wide range of infectious disease targets, including SARS-CoV-2, influenza, RSV, HPV, and more.
• Custom Solutions Available – Tailored reagents to meet specific research needs.
• Validated for Diagnostic and Therapeutic Applications – Trusted by leading biotech and pharmaceutical companies.

Millennium Science is a proud distributor of ACROBiosystems, offering exclusive access to their latest products and technical expertise.

Infectious diseases, caused by viruses, bacteria, fungi, and parasites, continue to pose significant global health risks. These diseases can spread through direct human contact, contaminated water, airborne transmission, and insect vectors. Some of the most pressing infectious diseases include:

• Respiratory Viruses – Influenza, respiratory syncytial virus (RSV), SARS-CoV-2
• Zoonotic Diseases – Rabies, Hendra virus, Nipah virus
• Oncogenic Viruses – Human papillomavirus (HPV), Epstein-Barr virus (EBV)
• Tropical & Vector-Borne Diseases – Malaria, dengue fever, chikungunya

With the ongoing threat of pandemics and emerging viral infections, researchers worldwide are focused on vaccine development, antiviral drug discovery, and improved diagnostic methods.

Since late 2019, the SARS-CoV-2 pandemic has highlighted the importance of robust virology research and vaccine development. Historically, diseases like smallpox, the plague, and the Spanish flu have had profound impacts on human society. Today, viruses such as influenza, rabies, RSV, and HPV continue to threaten global health.

To combat these challenges, scientists rely on high-quality recombinant proteins, neutralising antibodies, and assay development tools to accelerate vaccine research and therapeutic discoveries.

At Millennium Science, we are dedicated to supporting virologists, immunologists, and infectious disease researchers with cutting-edge reagents that drive progress. Our partnership with ACROBiosystems enables us to provide:

• Top-tier reagents for virus research, vaccine development, and drug discovery.
• Access to the latest recombinant proteins and antigens.
• Ongoing technical support and consultation for product selection and protocol optimisation.

Click below to search our extensive catalogue of ACROBiosystems reagents for your infectious disease research, and discover how Millennium Science can support your next breakthrough!